Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development

The 3-chymotrypsin-like cysteine protease (3CLpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a major target for the discovery of direct antiviral agents. We previously reported the evaluation of SARS-CoV-2 3CLpro inhibitors in a novel self-assembled monolayer deso...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cheng, Boland, Sandro, Scholle, Michael D., Bardiot, Dorothee, Marchand, Arnaud, Chaltin, Patrick, Blatt, Lawrence M., Beigelman, Leonid, Symons, Julian A., Raboisson, Pierre, Gurard-Levin, Zachary A., Vandyck, Koen, Deval, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839511/
https://www.ncbi.nlm.nih.gov/pubmed/33515606
http://dx.doi.org/10.1016/j.antiviral.2021.105020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839511/
https://www.ncbi.nlm.nih.gov/pubmed/33515606
http://dx.doi.org/10.1016/j.antiviral.2021.105020

Ejemplares similares